Article
B3GNT3 as a prognostic biomarker and correlation with immune cell infiltration in lung adenocarcinoma
1 Mar 2022
Abstract excerpt
Background: Lung adenocarcinoma (LUAD) is the most common malignant cancer in humans and because of low long-term survival rates, exploration of the molecular mechanisms underlying its progression, as well as novel prognostic predictors, is urgently needed. B3GNT3, a type II transmembrane protein located in the Golgi apparatus, is essential for forming extended core 1 oligosaccharides and is reportedly involved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
